Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Julio Isael Perez-Carreon"'
Autor:
Cecilia Rodriguez‐Monterrosas, Eduardo Perez Salazar, Pedro Cortes-Reynosa, Julio Isael Perez-Carreon, Alejandra Ordoñez-Moreno
Publikováno v:
Journal of Cellular Biochemistry. 118:2983-2992
Anemia is associated with chemotherapy treatment in cancer patients. Erythropoietin (EPO) has been used to treat anemia of cancer patients, because it stimulates erythropoiesis. However, treatment of breast cancer patients with EPO has been associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20453941487b7f1a0f2748cce424ec78
https://doi.org/10.1002/jcb.25959
https://doi.org/10.1002/jcb.25959
Autor:
Alejandra, Ordoñez-Moreno, Cecilia, Rodriguez-Monterrosas, Pedro, Cortes-Reynosa, Julio Isael, Perez-Carreon, Eduardo, Perez Salazar
Publikováno v:
Journal of cellular biochemistry. 118(9)
Anemia is associated with chemotherapy treatment in cancer patients. Erythropoietin (EPO) has been used to treat anemia of cancer patients, because it stimulates erythropoiesis. However, treatment of breast cancer patients with EPO has been associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7329fbf8e0cda3151d329a0813669cdd
https://pubmed.ncbi.nlm.nih.gov/28247960
https://pubmed.ncbi.nlm.nih.gov/28247960
Autor:
Barrett, Emma, Ivey, Gabrielle, Cunningham, Adam, Coffman, Gary, Pemberton, Tyera, Chan Lee, Patra, Prabir, Day, James B., Lee, Peter H. U., Shim, Joon W.
Publikováno v:
Frontiers in Aging Neuroscience; 2024, p1-11, 11p
Publikováno v:
Cancer Weekly; 10/29/2024, p536-536, 1p
Publikováno v:
Journal of Cellular Biochemistry; Sep2017, Vol. 118 Issue 9, p2475-2483, 9p
Autor:
Ordoñez‐Moreno, Alejandra, Rodriguez‐Monterrosas, Cecilia, Cortes‐Reynosa, Pedro, Perez‐Carreon, Julio Isael, Perez Salazar, Eduardo
Publikováno v:
Journal of Cellular Biochemistry; Sep2017, Vol. 118 Issue 9, p2983-2992, 10p
Autor:
Camacho, Javier
Cancer is one of the major causes of death worldwide. Despite hundreds of clinical trials currently in progress for cancer patients, the success rate is still very low. Understanding the molecular aspects of cancer development, the discovery of new m
